Results 141 to 150 of about 5,051 (197)

Investigation of colistin heteroresistance and the colistin resistance genes mcr-1 to mcr-5 in Escherichia coli and Klebsiella pneumoniae isolates in a tertiary hospital in Turkey

Journal of Infection in Developing Countries
Introduction: Heteroresistance is not detected by traditional antimicrobial susceptibility testing methods and may lead to treatment failures. Investigating the presence of plasmid-mediated colistin resistance genes is important because of the ...
Erkut Afyoncu, Canan Eryıldız
doaj   +1 more source

UEG Week 2024 Oral Presentations

United European Gastroenterology Journal, Volume 12, Issue S8, Page 9-200, October 2024.
wiley   +1 more source

Resistance and Heteroresistance to Colistin in Escherichia coli Isolates from Wenzhou, China

Infection and Drug Resistance, 2020
Wenli Liao,1,* Jie Lin,2,* Huaiyu Jia,1 Cui Zhou,1 Ying Zhang,3 Yishuai Lin,3 Jianzhong Ye,1 Jianming Cao,3 Tieli Zhou1 1Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, People ...
Liao W, Lin J, Jia H, Zhou C, Zhang Y, Lin Y, Ye J, Cao J, Zhou T   +8 more
doaj  

Activity of meropenem, against Gram-positive bacteria [PDF]

, 2017
A new carbapenem antibiotic, meropenem, was shown to be active against a large number of Gram-positive bacteria. The drug inhibited penicillinase-positive and -negative, methicillin-susceptible staphylococci equally well.
Hadorn, K., Kayser, F. H., Morenzoni, G., Strässle, A.   +3 more
core  

Imipenem Heteroresistance in Nontypeable Haemophilus influenzae

, 2019
In the post-vaccine era, the nontypeable (i.e. nonencapsulated) Haemophilus influenzae (NTHi) revealed as an opportunistic pathogen causing and exacerbating multiple upper and lower respiratory tract diseases. Worryingly, several studies in various post-vaccine populations have observed a steadily increase of NTHi invasive incidence rates and ...
openaire   +2 more sources

Heteroresistance [PDF]

, 2012
openaire   +2 more sources

Recent Advances in Understanding the Clinical Implications of Heterogeneous Drug Resistance in <i>Klebsiella pneumoniae</i>. [PDF]

Infect Drug Resist
Fang J, Lai H, Chen H, Tao Z, Cheng N, Xiang T.   +5 more
europepmc   +1 more source

Multicentre field evaluation of Xpert MTB/XDR in sub-Saharan Africa. [PDF]

ERJ Open Res
Massou F, Diarra B, Ba Diallo A, Bah KS, Vuchas C, Neh A, Sander M, Adebiyi EO, Aderemi BO, Agbla SC, Floyd S, Kaswa MK, Aloni M, Sissy M, Ushizimpumu B, Niyigena EB, Ngabonziza JCS, Abebe G, Tadesse M, Bah B, Camara L, Gaye Diallo A, Camara M, Diallo F, Togo ACG, Ferré A, Badalato N, Penn-Nicholson A, Schumacher SG, Odjougbele ST, Houeto S, Mulders W, Frissette K, Kebede W, El Tayeb O, Merle CS, de Jong BC, Supply P, Affolabi D, Rigouts L.   +39 more
europepmc   +1 more source

Evaluation of T-NGS, Xpert Ultra, and Line Probe Assay on Clinical Samples for the Diagnosis of Drug-Resistant Pulmonary Tuberculosis in Rio de Janeiro. [PDF]

Rev Soc Bras Med Trop
Bhering M, Ribeiro EP, Silveira AK, Lalucha C, Ribeiro EO, Igreja T, Pôrto LC, Secco D, Silva PEAD, Viveiros M, Oliveira M, Kritski A.   +11 more
europepmc   +1 more source

Clinical outcomes and molecular typing of heterogenous vancomycin-intermediate Staphylococcus aureus bacteremia in patients in intensive care units [PDF]

, 2015

core   +1 more source